-

Eurofins Scientific SE: Weekly Report on Share Repurchases from 3rd November to 7th November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins Scientific SE (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

03/11/2025

FR0014000MR3

10 000

60.8433

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

04/11/2025

FR0014000MR3

20 000

59.3784

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

05/11/2025

FR0014000MR3

20 000

59.1337

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

06/11/2025

FR0014000MR3

20 000

58.8260

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

07/11/2025

FR0014000MR3

20 000

57.8278

XPAR

 

 

 

TOTAL

90 000

59.0195

 

Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins Scientific SE

Eurofins Scientific SE

BOURSE:ERF
Release Versions
English

Contacts

Eurofins Scientific SE

More News From Eurofins Scientific SE

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF EUROFINS SCIENTIFIC SE – E1013 Identity of t...

Eurofins Medical Device Services Launches first GMP PFAS Screening and Testing Solutions for Medical Devices

LANCASTER, Pa.--(BUSINESS WIRE)--Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launched a GMP PFAS testing and screening solution, the first developed and commercialized for the medical device industry. This offering provides insights to medical device manufacturers as they navigate the complex and evolving global regulations surrounding PFAS, ultimately contributin...

Eurofins: Weekly Report on Share Repurchases From 24th November to 28th November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/11/2025 FR0014000MR3 20 000 58.4487 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/11/2025 FR0014000MR3 20 000 58.6804 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/1...
Back to Newsroom